Max Robotics — Global Service Robot Directory + US Certification

About

Dr. A.G. Morganti is a leading radiation oncologist whose research has fundamentally shaped the use of stereotactic body radiotherapy (SBRT) for challenging cancers, with a particular focus on pain palliation and toxicity reduction. His landmark 2018 systematic review on stereotactic radiotherapy for pancreatic cancer (64 citations) established SBRT as a critical tool for pain relief in locally advanced pancreatic carcinoma, a disease with notoriously poor prognosis. Dr. Morganti further advanced the field through his work on treatment planning for spinal radiosurgery (35 citations), providing technical frameworks that improved precision and safety. Most recently, he has pioneered the integration of artificial intelligence into radiation oncology, leading the multicenter ICAROS Study (2025) that developed a machine learning-based predictive model for acute toxicity in prostate cancer patients undergoing salvage radiotherapy. This work represents a significant step toward personalized treatment planning. His contributions extend to pediatric oncology, where he has explored CyberKnife approaches to minimize long-term radiation effects in children. With a career spanning from foundational SBRT techniques to cutting-edge AI applications, Dr. Morganti continues to drive innovation in making radiotherapy both more effective and safer for patients.